Amiodarone pharmacokinetics

https://doi.org/10.1016/0002-8703(83)90006-6Get rights and content

Abstract

The single-dose pharmacokinetics of amiodarone have been studied in volunteer subjects given 400 mg doses by the intravenous and oral routes. The data show the compound to have a very large volume of distribution, a low total clearance, and a long and variable terminal elimination half-life. In patients the terminal elimination half-life was on the order of 40 days, with a more rapid phase of elimination in the first few days following the withdrawal of therapy. The terminal elimination half-life of desethylamiodarone was longer than that of the parent compound. High concentrations of amiodarone and its desethyl metabolite were found in tissue samples, with fat forming a potentially large tissue reservoir of the drug.

References (24)

  • L Harris et al.

    Renal elimination of amiodarone and its desethyl metabolite

    Postgrad Med

    (1983)
  • MB Rosebaum et al.

    Clinical efficacy of amiodarone as an antiarrhythmic agent

    Am J Cardiol

    (1976)
  • Cited by (389)

    View all citing articles on Scopus
    View full text